Efficacy and safety of Chinese herbal medicines combined with cyclophosphamide for connective tissue disease-associated interstitial lung disease: A meta-analysis of randomized controlled trials.

Yin, Xietian; Zhao, Shichao; Xiang, Nan; Chen, Jidong; Xu, Jun; Zhang, Yudan

Yin, Xietian; Zhao, Shichao; Xiang, Nan; Chen, Jidong; Xu, Jun; Zhang, Yudan.

Afiliação

Yin X; College of the First Clinical, Hubei University of Chinese Medicine, Wuhan, China.
Zhao S; Department of Rheumatism Immunology, Hubei Provincial Hospital of TCM, Wuhan, China.
Xiang N; Department of Geriatrics, Hubei Provincial Hospital of TCM, Wuhan, China.
Chen J; College of the First Clinical, Hubei University of Chinese Medicine, Wuhan, China.
Xu J; College of the First Clinical, Hubei University of Chinese Medicine, Wuhan, China.
Zhang Y; College of the First Clinical, Hubei University of Chinese Medicine, Wuhan, China.

Front Pharmacol ; 14: 1064578, 2023.

Article em En | MEDLINE | ID: mdl-36909152

Palavras-chave

Chinese herbal medicine (CHM); connective tissue disease-associated interstitial lung disease; cyclophosphamide; metaanalysis; randomized controlled trials

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google